Taiwan FDA registration 8d1b56020c1b5ed0f5d3a05f174b635d
Constant IgM leprosy virus serum reagent (unsterilized)
TW: 常盈IgM痲疹病毒血清試劑(未滅菌)
Taiwan·Risk Class 1·IBL INTERNATIONAL GMBH·Registered Sep 28, 2005 – Sep 28, 2020CancelledRegistration details
- Analysis ID
- 8d1b56020c1b5ed0f5d3a05f174b635d
- Customs Code
- DHA04400062800
Company information
- Manufacturer
- IBL INTERNATIONAL GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- 利用非放射性體外酵素定性免疫方法檢測血液/血漿中 Measles IgM,可做痲疹病毒檢測.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3520 麻疹病毒血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Sep 28, 2005
- Expiry Date
- Sep 28, 2020
- Cancellation Date
- Jun 22, 2022
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Constant IgM leprosy virus serum reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 8d1b56020c1b5ed0f5d3a05f174b635d and manufactured by IBL INTERNATIONAL GMBH. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices